BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 8877920)

  • 1. Self-assessment of disease activity by patients with rheumatoid arthritis.
    Hanly JG; Mosher D; Sutton E; Weerasinghe S; Theriault D
    J Rheumatol; 1996 Sep; 23(9):1531-8. PubMed ID: 8877920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical measures in rheumatoid arthritis: which are most useful in assessing patients?
    Ward MM
    J Rheumatol; 1994 Jan; 21(1):17-27. PubMed ID: 7864914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient self-report tender and swollen joint counts in early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Wong AL; Wong WK; Harker J; Sterz M; Bulpitt K; Park G; Ramos B; Clements P; Paulus H
    J Rheumatol; 1999 Dec; 26(12):2551-61. PubMed ID: 10606362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of patient-reported joint counts in rheumatoid arthritis and the role of training.
    Levy G; Cheetham C; Cheatwood A; Burchette R
    J Rheumatol; 2007 Jun; 34(6):1261-5. PubMed ID: 17444590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-administered joint counts in rheumatoid arthritis: comparison with standard joint counts.
    Calvo FA; Calvo A; Berrocal A; Pevez C; Romero F; Vega E; Cusi R; Visaga M; De La Cruz RA; Alarcón GS
    J Rheumatol; 1999 Mar; 26(3):536-9. PubMed ID: 10090158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient self-administered joint tenderness counts in rheumatoid arthritis are reliable and responsive to changes in disease activity.
    Figueroa F; Braun-Moscovici Y; Khanna D; Voon E; Gallardo L; Luinstra D; Pina X; Henstorf G; Laurence S; Neiman R; Furst D
    J Rheumatol; 2007 Jan; 34(1):54-6. PubMed ID: 17216678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate.
    Yazici Y; Pincus T; Kautiainen H; Sokka T
    J Rheumatol; 2004 Sep; 31(9):1723-6. PubMed ID: 15338490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The uses of disease activity scoring and the physician global assessment of disease activity for managing rheumatoid arthritis in rheumatology practice.
    Harrington JT
    J Rheumatol; 2009 May; 36(5):925-9. PubMed ID: 19369466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why not use OSRA? A comparison of Overall Status in Rheumatoid Arthritis (RA) with ACR core set and other indices of disease activity in RA.
    Birrell FN; Hassell AB; Jones PW; Dawes PT
    J Rheumatol; 1998 Sep; 25(9):1709-15. PubMed ID: 9733450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in clinical status measures in different ethnic/racial groups with early rheumatoid arthritis: implications for interpretation of clinical trial data.
    Yazici Y; Kautiainen H; Sokka T
    J Rheumatol; 2007 Feb; 34(2):311-5. PubMed ID: 17304656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sources of discrepancy in patient and physician global assessments of rheumatoid arthritis disease activity.
    Nicolau G; Yogui MM; Vallochi TL; Gianini RJ; Laurindo IM; Novaes GS
    J Rheumatol; 2004 Jul; 31(7):1293-6. PubMed ID: 15229946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are patient self-report measures of arthritis activity confounded by mood? A longitudinal study of patients with rheumatoid arthritis.
    Ward MM
    J Rheumatol; 1994 Jun; 21(6):1046-50. PubMed ID: 7932413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative contributions of the components of the American College of Rheumatology 20% criteria for improvement to responder status in patients with early seropositive rheumatoid arthritis.
    Paulus HE; Bulpitt KJ; Ramos B; Park G; Wong WK;
    Arthritis Rheum; 2000 Dec; 43(12):2743-50. PubMed ID: 11145032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores.
    Yazici Y; Bergman M; Pincus T
    J Rheumatol; 2008 Apr; 35(4):603-9. PubMed ID: 18322993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test-retest reliability of patient global assessment and physician global assessment in rheumatoid arthritis.
    Rohekar G; Pope J
    J Rheumatol; 2009 Oct; 36(10):2178-82. PubMed ID: 19755617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.
    Sokka T; Pincus T
    J Rheumatol; 2003 Jun; 30(6):1138-46. PubMed ID: 12784382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?
    Soubrier M; Zerkak D; Gossec L; Ayral X; Roux C; Dougados M
    J Rheumatol; 2006 Jul; 33(7):1243-6. PubMed ID: 16622906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.